Microfluidics Market (By Material: Glass, Silicon, PDMS, Polymers, and Others; By Technology: Non-Medical and Medical; By Application: Organs-on-chips, Lab-on-a-chip, Continuous Flow Microfluidics, Acoustofluidics and Microfluidics, Optofluidics and Microfluidics, and Electrophoresis and Microfluidics) - Global Market Size, Trends Analysis, Segment Forecasts, Regional Outlook 2023 - 2032

The global microfluidics market size accounted for USD 20 billion in 2022 and is expected to hit around USD 81.26 billion by 2032, poised to grow at a CAGR of 15.1% during the forecast period from 2023 to 2032. 

Microfluidics Market Size 2021 to 2030

To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics

Key Takeaways

  • North America led the global market with the highest market share of 43% in 2022.
  • By Material, the polydimethylsiloxane (PDMS) segment is estimated to hold the highest market share of 34.5% in 2022.
  • By Technology, the medical technology segment has held the biggest revenue share of 83% in 2022.
  • By Application, the lab-on-a-chip segment had the largest market share of 38% in 2022.

Microfluidics Market in the U.S. 2023-2032

The U.S. microfluidics market size was valued at USD 5.28 billion in 2022 and is estimated to reach around USD 21.45 billion by 2032, growing at a CAGR of 15.10% from 2023 to 2032.

U.S. Microfluidics Market Size 2023 To 2032

North America emerged as the largest share holder around 43% in the global microfluidics market owing to the presence of well-established market players in the region, introduction of advanced technologies, an increase in the number of studies being opted to improve the samples optimization, and significant demand for POC diagnostics. In addition to this, the active participation of research institutes towards the development of novel microfluidic devices predicted to retain the dominance of the region over the upcoming years.

However, the Asia Pacific encountered to be the fastest growing market because of affordable labor, sophisticated research infrastructure, and adoption of microfluidic platforms. Furthermore, several international players have shown their interest for investing in this untapped market. For instance, in November 2019, Select BIO Microfluidics and Organ-on-a-Chip Asia organized a conference in Japan for addressing some novel technologies in the fields of Lab-on-a-Chip, Organ-on-a-Chip, and Microfluidics.

Microfluidics Market Share, By Region, 2020 (%)

Growth Factors

Increase in demand for point-of-care (POC) devices anticipated to prominently boost the market size in the upcoming years. Significant demand for low-volume sample analysis, demand for In Vitro Diagnostics (IVD), high-throughput screening methodologies, and development of advanced lab-on-a-chip technologies are further expected to propel the market growth of microfluidics over the analysis timeframe. Microfluidics provides a high return on investment along with it also helps in controlling cost by minimizing errors.

Other key factors propelling the market growth for microfluidics include increasing for microfluidics technology & devices in point-of-care diagnostics, rising technological advancements in diagnostic devices, and rising incidence of chronic diseases across the globe. Hence, the above mentioned factors augment the demand for molecular diagnosis and subsequently impact positively towards the market growth of the microfluidics.

Microfluidics Market Scope 

Report Highlights Details
Growth Rate from 2023 to 2032 CAGR of 15.1%
Market Size in 2023 USD 22.92 Billion
Market Size by 2032 USD 81.26 Billion
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered Material, Technology, Application, Region
Companies Mentioned Qiagen N.V., Agilent Technologies, Inc., Illumina, Inc., Perkinelmer, Inc., Thermo Fischer Scientific, Life Technologies Corporation, Danaher, Bio-Rad Laboratories, Inc., Cellix Ltd.,Hoffmann-La Roche Ltd, Abbott Laboratories


Material Insights

The polydimethylsiloxane (PDMS)-based microfluidic chips segment dominated the global microfluidics market in terms of revenue at 34.5% in the year 2022 and is anticipated to register the fastest growth rate over the analysis period. PDMS is a prominently used polymer in fast prototyping microfluidic devices. These are highly used by the academic community owing to their ease of fabrication along with their low cost. On the other hand, these polymers are hydrophobic which makes microchannels hard to operate in aqueous solutions. To combat this issue, new PDMS surface modifications are offered to address challenges due to hydrophobicity.

Microfluidics Market Share, By Material, 2020 (%)

Besides this, polymer-based microfluidic devices proved as a better alternative to the glass and silicon-based microfluidic devices. Polymer-based materials are more affordable, robust, easy to access, and require rapid fabrication techniques as compared to silicon and glass materials. Polymers are one of the most important materials used in microfluidic chips for mass production by applying soft lithography, casting, injection molding, and hot embossing techniques.

Technology Insights

On the basis of revenue,the medical technology segment led the global microfluidics market with an 83% revenue share in the year 2022. This is mainly attributed to the three major benefits offered by the microfluidics for the POC diagnostics that include smaller sample volumes, faster turnaround times, and lesser test costs. These benefits are moderately being utilized for the development of POC devices for detection and diagnosis of a wide range of conditions from cancer to infectious diseases.

Microfluidics Market Share, By Technology, 2020 (%)

For example, the Laboratory of Integrated Bio-Medical/Nanotechnology & Applications (LIBNA) fabricated a microfluidic point-of-care sepsis chip that calculates CD64 expression on neutrophils as well as the overall WBC count in around 30 minutes, by just using 10 microliters of a blood sample. 

Application Insights

The lab-on-a-chip application accounted revenue share of 38% in the global microfluidics market in the year 2022 and estimated to continue its position throughout the analysis period. In the field of molecular biology, lab-on-a-chip provides high detection speed despite of maintaining the same sensitivity level during RNA or DNA amplification along with their detection procedures. This application also permits the rapid sequencing of DNA.

Elveflow provides the fastest qPCR system named as Fast gene system that detects viruses and bacteria within 7 minutes. Furthermore, nanopore technology holds an excessive potential to facilitate the rapid genome sequencing of DNA than the lab-on-a-chip by implementing an array technique.

Key Companies & Market Share Insights

The global microfluidics market seeks to be highly competitive in nature because of the market players are significantly investing towards new product development and advancement. For instance, in March 2019, Dolomite Microfluidics introduced a novel microencapsulation system, named as µEncapsulator Systems. The system encapsulates nearly 300,000 cells into monodisperse droplets within a time span of just 15 minutes.

Some of the prominent players in the microfluidics market include:

  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Perkinelmer, Inc.
  • Life Technologies Corporation
  • Danaher
  • Bio-Rad Laboratories, Inc.
  • Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Fluidigm Corporation
  • Qiagen N.V.
  • Thermo Fischer Scientific
  • Biomérieux
  • Cellix Ltd.
  • Elveflow
  • Micronit Micro Technologies B.V.

Segments Covered in the Report

This research study comprises complete assessment of the market by means of far-reaching qualitative and quantitative perceptions, and predictions regarding the market. This report delivers classification of marketplace into impending and niche sectors. Further, this research study calculates market size and its development drift at global, regional, and country from 2020 to 2032. This report contains market breakdown and its revenue estimation by classifying iton the basis ofmaterial, technology, application, and region:

By Material

  • Glass
  • Silicon
  • PDMS
  • Polymers
  • Others

By Technology

  • Non-Medical
  • Medical
    • Gel Electrophoresis
    • PCR & RT-PCR
    • ELISA
    • Microarrays
    • Others

By Application

  • Organs-on-chips
  • Lab-on-a-chip
  • Continuous Flow Microfluidics
  • Acoustofluidics and Microfluidics
  • Optofluidics and Microfluidics
  • Electrophoresis and Microfluidics

By Regional Outlook

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Frequently Asked Questions

What is the market size of microfluidics market?
The microfluidics market size was valued at USD 20 billion in 2022 and is predicted to hit around USD 81.26 billion by 2032.
What is the microfluidics market growth?
The microfluidics market grow is anticipated to grow at a CAGR of 15.1% from 2023 to 2032.
Which major factors are driving the microfluidics market growth?
Rising demand for Point of Care (POC) testing in a wide range of applications because of the benefits associated with the incorporation of microfluidics along with high return on investments anticipated to propel the market growth of microfluidics during the analysis period. In addition, high-throughput screening methodologies, low-volume sample analysis, and increased demand for in vitro diagnostics (IVD) expected to offer numerous growth opportunities for the players operating in the microfluidics market during the forthcoming years.
Which segment was accounted for the largest microfluidics market share?
The lab-on-a-chip application accounted for the largest value share in the global market and estimated to continue its dominance throughout the analysis period.
Who are the key players in microfluidics market?
Some of the key players operating in the market are Qiagen N.V., Agilent Technologies, Inc., Illumina, Inc., Perkinelmer, Inc., Thermo Fischer Scientific, Life Technologies Corporation, Danaher, Bio-Rad Laboratories, Inc., Cellix Ltd.,Hoffmann-La Roche Ltd, Abbott Laboratories, Fluidigm Corporation, biomérieux, Elveflow, and Micronit Micro Technologies B.V. among others.
Which region was accounted for the largest microfluidics market share?
North America holds the largest value share in the global market for microfluidics. The growth of the region is mainly attributed to better reimbursement policies, well-established healthcare system, and the higher adoption of novel therapeutics among the common population.


   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500


No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Get a Sample